Effects on the Immune System 419Klein TW, Friedman H (1990) Modulation of murine immune cell function by marijuana
components. In: Watson R (ed) Drugs of abuse and immune function. CRC Press, Boca
Raton, pp 87–111
Klein TW, Newton CA, Widen R, Friedman H (1985) The effect of delta-9-tetrahydro-
cannabinol and 11-hydroxy-delta-9-tetrahydrocannabinol on T-lymphocyte and B-
lymphocyte mitogen responses. J Immunopharmacol 7:451–466
Klein TW, Kawakami Y, Newton C, Friedman H (1991) Marijuana components suppress
induction and cytolytic function of murine cytotoxic T cells in vitro and in vivo.
J Toxicol Environ Health 32:465–477
Klein TW, Newton C, Widen R, Friedman H (1993) Delta-9-tetrahydrocannabinol injection
induces cytokine-mediated mortality of mice infected with Legionella pneumophila.
J Pharmacol Exp Ther 267:635–640
Klein TW, Friedman H, Specter S (1998a) Marijuana, immunity and infection. J Neuroim-
munol 83:102–115
Klein TW, Newton C, Friedman H (1998b) Cannabinoid receptors and immunity. Immunol
Today 19:373–381
Klein TW, Newton CA, Nakachi N, Friedman H (2000) Delta-9-tetrahydrocannabinol treat-
ment suppresses immunity and early IFN-gamma, IL-12, and IL-12 receptor beta 2
responses to Legionella pneumophila infection. J Immunol 164:6461–6466
Klein TW, Newton C, Snella E, Friedman H (2001) Marijuana, the cannabinoid system, and
immunomodulation. In: Ader R, Felten DL, Cohen N (eds) Psychoneuroimmunology.
Academic Press, San Diego, pp 415–432
Klykken PC, Smith SH, Levy JA, Razdan R, Munson AE (1977) Immunosuppressive effects
of 8,9-epoxyhexahydrocannabinol (EHHC). J Pharmacol Exp Ther 201:573–579
Kusher DI, Dawson LO, Taylor AC, Djeu JY (1994) Effect of the psychoactive metabolite
of marijuana, delta-9-tetrahydrocannabinol (THC), on the synthesis of tumor necrosis
factor by human large granular lymphocytes. Cell Immunol 154:99–108
Lambert DM, DiPaolo FG, Sonveaux P, Kanyonyo M, Govaerts SJ, Hermans E, Bueb J,
Delzenne NM, Tschirhart EJ (1999) Analogues and homologues of N-palmitoylethanol-
amide, a putative endogenous CB2 cannabinoid, as potential ligands for the cannabinoid
receptors. Biochim Biophys Acta 1440:266–274
Lawrence T, Willoughby DA, Gilroy DW (2002) Anti-inflammatory lipid mediators and
insights into the resolution of inflammation. Nat Rev Immunol 2:787–795
Lee M, Yang KH, Kaminski NE (1995) Effects of putative cannabinoid receptor ligands, anan-
damide and 2-arachidonyl-glycerol, on immune function in B6C3F1 mouse splenocytes.
J Pharmacol Exp Ther 275:529–536
Lee SF, Newton C, Widen R, Friedman H, Klein TW (2001a) Downregulation of cannabinoid
receptor 2 (CB2) messenger RNA expression during in vitro stimulation of murine
splenocytes with lipopolysaccharide. Adv Exp Med Biol 493:223–228
Lee SF, Newton C, Widen R, Friedman H, Klein TW (2001b) Differential expression of
cannabinoid CB(2) receptor mRNA in mouse immune cell subpopulations and following
B cell stimulation. Eur J Pharmacol 423:235–241
LefkowitzSS,KlagerK(1978)Effectofdelta-9-tetrahydrocannabinoloninvitrosensitization
of mouse splenic lymphocytes. Immunol Commun 7:557–566
Li X, Kaminski NE, Fischer LJ (2001) Examination of the immunosuppressive effect of
delta-9-tetrahydrocannabinol in streptozotocin-induced autoimmune diabetes. Int Im-
munopharmacol 1:699–712
LiauA,DiclementeRJ,WingoodGM,CrosbyRA,WilliamsKM,HarringtonK,DaviesSL,
Hook EW, III, Oh MK (2002) Associations between biologically confirmed marijuana
use and laboratory-confirmed sexually transmitted diseases among African American
adolescent females. Sex Transm Dis 29:387–390
Lozada F, Silverman S Jr, Migliorati CA, Conant MA, Volberding PA (1983) Oral mani-
festations of tumor and opportunistic infections in the acquired immunodeficiency
syndrome (AIDS): findings in 53 homosexual men with Kaposi’s sarcoma. Oral Surg
Oral Med Oral Pathol 56:491–494